On February 17, the 2022 “Digital Health Companies China 50” list was released at the “2023 MIT Technology Review China Future Health” Summit. As one of the most important benchmarks of digital health, the list consists of 50 outstanding healthcare science and technology companies from six major fields that affect digital health. Among the 50, five promising AI-driven biotech companies including Evergreen Therapeutics, Insilico Medicine, XtalPi were recognized by virtue of their outstanding achievements in the field of digitalization of pharmaceutical R&D.